Nifty
Sensex
:
:
16352.45
54884.66
182.30 (1.13%)
632.13 (1.17%)

Pharmaceuticals & Drugs - Global

Rating :
59/99

BSE: 524742 | NSE: CAPLIPOINT

732.60
27-May-2022
  • Open
  • High
  • Low
  • Previous Close
  •  746.00
  •  752.10
  •  731.00
  •  739.90
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  31854
  •  235.32
  •  1034.80
  •  585.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 5,604.69
  • 18.95
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 5,162.18
  • 0.27%
  • 3.83

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 68.89%
  • 1.85%
  • 20.79%
  • FII
  • DII
  • Others
  • 2.07%
  • 1.19%
  • 5.21%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 21.45
  • 17.83

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 21.37
  • 7.23

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 20.44
  • 11.12

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 22.38
  • 19.14
  • 17.54

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.06
  • 7.26
  • 4.01

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.78
  • 14.96
  • 11.52

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Jun 21
Jun 20
Var%
Net Sales
339.24
278.71
21.72%
326.20
274.39
18.88%
303.53
268.12
13.21%
300.44
240.08
25.14%
Expenses
239.30
193.02
23.98%
225.24
190.46
18.26%
202.36
180.69
11.99%
207.83
168.48
23.36%
EBITDA
99.94
85.69
16.63%
100.96
83.93
20.29%
101.17
87.43
15.72%
92.61
71.60
29.34%
EBIDTM
29.46%
30.75%
30.95%
30.59%
33.33%
32.61%
30.82%
29.82%
Other Income
11.51
9.46
21.67%
9.54
5.82
63.92%
8.49
1.76
382.39%
9.21
6.49
41.91%
Interest
0.08
0.32
-75.00%
0.14
0.28
-50.00%
0.21
0.48
-56.25%
0.27
0.51
-47.06%
Depreciation
11.45
9.86
16.13%
11.70
9.27
26.21%
11.72
8.88
31.98%
12.03
8.96
34.26%
PBT
99.92
84.97
17.59%
98.66
80.20
23.02%
97.73
79.83
22.42%
89.52
68.62
30.46%
Tax
19.09
17.05
11.96%
19.38
14.06
37.84%
20.91
17.00
23.00%
17.99
14.07
27.86%
PAT
80.83
67.92
19.01%
79.28
66.14
19.87%
76.82
62.83
22.27%
71.53
54.55
31.13%
PATM
23.83%
24.37%
24.30%
24.10%
25.31%
23.43%
23.81%
22.72%
EPS
10.43
8.77
18.93%
9.89
8.52
16.08%
9.91
7.52
31.78%
9.37
7.21
29.96%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Jun 13
Jun 12
Net Sales
1,269.41
1,061.29
863.20
648.69
539.84
401.65
238.72
251.77
173.09
127.03
107.22
Net Sales Growth
19.61%
22.95%
33.07%
20.16%
34.41%
68.25%
-5.18%
45.46%
36.26%
18.48%
 
Cost Of Goods Sold
557.50
471.74
413.16
288.78
238.18
184.93
121.16
135.62
102.58
84.45
77.36
Gross Profit
711.91
589.55
450.04
359.91
301.66
216.72
117.56
116.15
70.50
42.58
29.85
GP Margin
56.08%
55.55%
52.14%
55.48%
55.88%
53.96%
49.25%
46.13%
40.73%
33.52%
27.84%
Total Expenditure
874.73
732.65
603.13
416.84
344.52
276.84
174.51
192.06
136.90
104.68
96.06
Power & Fuel Cost
-
16.36
14.81
13.76
10.98
9.91
7.56
8.61
3.07
1.12
0.84
% Of Sales
-
1.54%
1.72%
2.12%
2.03%
2.47%
3.17%
3.42%
1.77%
0.88%
0.78%
Employee Cost
-
101.96
67.15
45.58
37.61
29.71
17.92
18.24
12.63
7.69
6.28
% Of Sales
-
9.61%
7.78%
7.03%
6.97%
7.40%
7.51%
7.24%
7.30%
6.05%
5.86%
Manufacturing Exp.
-
69.85
68.23
43.49
37.11
28.56
14.33
16.04
7.42
3.07
1.63
% Of Sales
-
6.58%
7.90%
6.70%
6.87%
7.11%
6.00%
6.37%
4.29%
2.42%
1.52%
General & Admin Exp.
-
38.54
25.50
20.82
12.27
13.78
8.15
7.97
6.54
4.67
3.58
% Of Sales
-
3.63%
2.95%
3.21%
2.27%
3.43%
3.41%
3.17%
3.78%
3.68%
3.34%
Selling & Distn. Exp.
-
18.03
9.95
2.08
5.92
9.41
2.29
2.85
1.46
1.02
0.91
% Of Sales
-
1.70%
1.15%
0.32%
1.10%
2.34%
0.96%
1.13%
0.84%
0.80%
0.85%
Miscellaneous Exp.
-
16.16
4.33
2.33
2.45
0.55
3.10
2.72
3.19
2.66
0.91
% Of Sales
-
1.52%
0.50%
0.36%
0.45%
0.14%
1.30%
1.08%
1.84%
2.09%
5.07%
EBITDA
394.68
328.64
260.07
231.85
195.32
124.81
64.21
59.71
36.19
22.35
11.16
EBITDA Margin
31.09%
30.97%
30.13%
35.74%
36.18%
31.07%
26.90%
23.72%
20.91%
17.59%
10.41%
Other Income
38.75
23.54
41.33
19.03
12.67
9.96
3.66
3.03
3.72
2.10
2.51
Interest
0.70
1.59
0.32
0.58
0.61
0.52
0.34
0.97
0.68
0.77
1.26
Depreciation
46.90
36.97
31.62
23.43
19.00
13.30
7.48
8.38
3.54
1.54
1.24
PBT
385.83
313.62
269.46
226.88
188.38
120.95
60.05
53.39
35.69
22.14
11.17
Tax
77.37
62.19
54.38
50.32
43.74
25.44
14.28
12.26
9.76
8.12
3.14
Tax Rate
20.05%
19.83%
20.18%
22.18%
23.22%
21.03%
23.78%
22.96%
27.35%
36.68%
28.11%
PAT
308.46
242.27
215.00
176.56
144.78
95.61
45.77
41.04
25.85
13.98
8.01
PAT before Minority Interest
299.84
251.43
215.08
176.56
144.63
95.50
45.77
41.13
25.93
14.02
8.03
Minority Interest
-8.62
-9.16
-0.08
0.00
0.15
0.11
0.00
-0.09
-0.08
-0.04
-0.02
PAT Margin
24.30%
22.83%
24.91%
27.22%
26.82%
23.80%
19.17%
16.30%
14.93%
11.01%
7.47%
PAT Growth
22.68%
12.68%
21.77%
21.95%
51.43%
108.89%
11.53%
58.76%
84.91%
74.53%
 
EPS
40.69
31.96
28.36
23.29
19.10
12.61
6.04
5.41
3.41
1.84
1.06

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Jun 13
Jun 12
Shareholder's Funds
1,185.82
947.91
632.91
363.83
224.76
128.14
93.19
61.74
43.14
33.58
Share Capital
89.71
89.71
51.05
15.12
15.12
15.11
15.11
15.11
15.11
15.11
Total Reserves
1,081.31
848.76
575.01
345.42
209.56
111.40
78.08
46.63
28.03
18.47
Non-Current Liabilities
17.39
24.86
23.42
27.86
19.90
13.69
10.39
10.42
8.66
4.29
Secured Loans
0.00
0.02
0.29
0.32
0.48
0.73
0.88
2.07
3.48
1.55
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
5.70
5.23
0.13
0.00
0.40
1.63
0.82
0.81
0.38
0.27
Current Liabilities
142.85
144.32
86.11
108.67
113.36
125.04
124.97
107.58
83.01
69.20
Trade Payables
88.50
64.14
60.47
94.23
78.60
55.71
41.56
31.50
25.64
21.26
Other Current Liabilities
54.27
79.28
24.20
13.86
33.09
60.39
72.11
66.42
50.85
38.33
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
0.05
0.05
0.05
5.20
Short Term Provisions
0.09
0.91
1.44
0.58
1.67
8.94
11.25
9.60
6.47
4.41
Total Liabilities
1,363.60
1,125.75
742.52
500.45
358.38
267.14
228.82
179.92
134.90
107.12
Net Block
305.40
272.50
226.84
169.48
151.83
144.23
113.13
102.24
32.71
27.54
Gross Block
422.57
354.79
271.51
231.79
195.15
180.76
142.71
123.06
50.06
43.36
Accumulated Depreciation
117.17
82.29
44.67
62.31
43.31
36.53
29.58
20.82
17.36
15.82
Non Current Assets
327.80
303.23
248.83
196.34
179.16
148.61
146.95
131.30
96.21
53.41
Capital Work in Progress
13.82
20.12
9.70
15.29
3.42
0.23
30.63
24.54
48.98
12.79
Non Current Investment
0.66
0.56
0.33
0.33
13.24
0.44
0.45
0.44
1.19
1.14
Long Term Loans & Adv.
7.92
10.05
11.95
11.23
10.67
3.71
2.75
3.67
10.83
11.94
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
1,035.81
822.53
493.69
304.11
179.22
118.53
81.87
48.61
38.70
53.71
Current Investments
10.54
60.23
69.62
46.34
4.20
0.00
0.00
0.00
0.00
0.00
Inventories
179.00
238.23
37.45
28.46
22.29
18.81
13.66
9.79
10.42
6.38
Sundry Debtors
279.36
228.96
159.81
125.88
33.02
7.95
5.66
0.09
0.86
7.28
Cash & Bank
459.58
223.43
152.99
79.28
93.07
68.10
45.37
26.82
16.84
31.80
Other Current Assets
107.33
14.87
9.22
6.88
26.63
23.67
17.18
11.90
10.57
8.25
Short Term Loans & Adv.
87.08
56.81
64.61
17.28
19.31
12.58
11.08
8.16
5.61
4.50
Net Current Assets
892.95
678.21
407.58
195.44
65.86
-6.51
-43.10
-58.97
-44.31
-15.49
Total Assets
1,363.61
1,125.76
742.52
500.45
358.38
267.14
228.82
179.91
134.91
107.12

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Jun 13
Jun 12
Cash From Operating Activity
265.77
44.68
83.42
66.49
67.61
42.40
49.88
59.83
31.95
27.92
PBT
313.62
269.46
226.88
188.38
120.95
60.05
53.39
35.69
22.14
11.17
Adjustment
23.09
7.09
19.12
14.84
8.61
3.87
6.21
2.14
-0.21
-0.25
Changes in Working Capital
-4.80
-177.11
-120.06
-100.38
-38.39
-5.13
1.96
29.32
15.81
18.89
Cash after chg. in Working capital
331.91
99.44
125.94
102.84
91.16
58.78
61.56
67.15
37.75
29.81
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-66.14
-54.76
-42.51
-36.35
-23.55
-16.38
-11.67
-7.32
-5.80
-1.89
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-5.36
-54.50
-100.46
-69.02
-36.11
-5.72
-22.66
-43.89
-45.44
-16.44
Net Fixed Assets
-35.46
-43.65
58.45
-48.43
-19.56
-7.66
-25.72
-48.50
-43.00
-16.08
Net Investments
46.59
-27.53
-120.03
-29.43
-17.35
0.01
-0.90
0.75
-0.05
-0.04
Others
-16.49
16.68
-38.88
8.84
0.80
1.93
3.96
3.86
-2.39
-0.32
Cash from Financing Activity
-23.98
79.77
89.79
-11.60
-6.74
-13.95
-8.67
-5.96
-1.48
-1.30
Net Cash Inflow / Outflow
236.44
69.94
72.76
-14.13
24.76
22.73
18.55
9.99
-14.97
10.18
Opening Cash & Equivalents
220.77
150.65
77.17
91.31
66.55
45.37
26.82
16.84
31.80
21.62
Closing Cash & Equivalent
456.96
220.77
150.65
77.17
91.31
68.10
45.37
26.82
16.84
31.80

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Jun 13
Jun 12
Book Value (Rs.)
144.95
114.21
78.03
47.69
29.73
16.25
11.84
7.68
5.22
3.95
ROA
20.20%
23.02%
28.41%
33.68%
30.54%
18.46%
20.12%
16.48%
11.59%
9.00%
ROE
25.65%
29.58%
37.14%
49.43%
54.97%
43.13%
55.78%
53.24%
40.49%
29.10%
ROCE
28.82%
33.35%
45.59%
64.08%
69.03%
55.41%
71.11%
68.99%
56.69%
34.62%
Fixed Asset Turnover
2.73
2.76
2.58
2.53
2.14
1.48
1.89
2.00
2.73
2.61
Receivable days
87.41
82.19
80.37
53.72
18.62
10.40
4.17
1.00
11.66
26.30
Inventory Days
71.75
58.28
18.54
17.16
18.68
24.83
17.00
21.31
24.06
20.01
Payable days
59.05
28.33
65.76
89.68
88.17
103.48
69.75
79.69
85.60
79.07
Cash Conversion Cycle
100.11
112.15
33.15
-18.80
-50.88
-68.24
-48.58
-57.39
-49.89
-32.75
Total Debt/Equity
0.01
0.04
0.00
0.00
0.00
0.02
0.02
0.06
0.12
0.23
Interest Cover
198.29
843.86
391.22
309.72
235.08
179.35
56.11
53.29
29.73
9.88

News Update:


  • Caplin Point Lab - Quarterly Results
    12th May 2022, 13:03 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.